US Material Events SEC 8-K Filings — April 29, 2026

29-04-2026

Kopin Corporation announced a strategic collaboration with Fabric.AI to develop Neural I/o™ MicroLED-based optical interconnect technology for AI infrastructure, securing a $15M initial development order to fund the demonstration chipset. Under the agreement, Kopin owns 19.9% of Fabric.AI and will serve as the exclusive manufacturer of the Neural I/o™ chipsets. This partnership leverages Kopin's MicroLED expertise to address power and bandwidth challenges in AI data centers, positioning the company as a key player in the expanding AI hardware ecosystem.

• ·Announcement date: April 28, 2026
• ·Filing date: April 29, 2026
• ·Kopin has over 40 years of experience in advanced display technologies

29-04-2026

Atkore Inc. entered into settlement agreements on April 28, 2026, agreeing to pay $72.5 million to Direct Purchaser Plaintiffs and $64 million to Non-Converter Seller Purchaser Plaintiffs (totaling $136.5 million) in the In re PVC Pipe Antitrust Litigation, to be recorded as a non-operating expense in the quarter ended March 27, 2026. The company expects no material adverse effect on liquidity or leverage metrics and believes the settlements reduce legal uncertainty without admitting fault. However, End User Plaintiffs' claims remain pending, and court approval is required with no assurance of finalization.

• ·Settlement payments to be made on or about 21 days after preliminary court approval.
• ·Execution does not constitute admission of fault or liability.
• ·Company plans to vigorously defend if settlements not approved.
• ·Litigation centralized in U.S. District Court for the Northern District of Illinois.

29-04-2026

OppFi Inc. announced a definitive agreement to acquire BNCCORP, Inc. and BNC National Bank in a cash and stock transaction valued at approximately $130 million, expected to close in Q4 2026, combining OppFi's digital lending platform with BNC's national bank charter for geographic expansion, product diversification, and synergies of at least $60 million in year 1 post-closing. The deal is projected to be significantly accretive with adjusted EPS growth of more than 25% in 2027 and more than 40% in 2028, alongside adjusted ROA of 10%+ and ROE of 35%+ by 2028. OppFi also simplified its corporate structure by collapsing its Up-C into a traditional C-Corp, terminating the TRA with a $40.8 million payment but recording $466 million in tax amortizable goodwill expected to yield $111 million in future cash tax savings.

• ·BNC headquartered in Glendale, AZ, with deposit cost of less than 2%.
• ·Transaction approved by both boards; subject to BNCC stockholder approval, OCC, Federal Reserve, FDIC approvals.
• ·OppFi to become bank holding company; contribute assets to OppFi Bank, N.A.; BNC as community banking division led by Dan Collins.
• ·OppFi holds 35% equity in Bitty Holdings, LLC.

29-04-2026

Two Harbors Investment Corp (TWO) and CrossCountry Mortgage, LLC (CCM) announced an amended merger agreement, increasing the per-share cash consideration for TWO common stock to $11.30 from $10.80 under the original terms, following a review of an unsolicited competing proposal from UWM Holdings Corporation on April 20, 2026. TWO's Board unanimously approved the amendment, recommending stockholders vote in favor at the special meeting on May 19, 2026, with closing expected in Q3 2026; Series A, B, and C Preferred Stock will be redeemed at $25.00 per share plus dividends. The deal provides fixed all-cash consideration without financing conditions, deemed superior for certainty.

• ·Original merger agreement dated March 27, 2026.
• ·TWO headquartered in St. Louis Park, MN.
• ·CCM operates in all 50 states, D.C., and Puerto Rico; NMLS #3029.
• ·Advisors: Houlihan Lokey (financial) and Jones Day (legal) for TWO; Citi (exclusive financial) and Simpson Thacher & Bartlett LLP (legal) for CCM.
• ·TWO to file proxy supplement; prior votes remain valid but changeable.
• ·TWO intends regular quarterly dividends pre-closing.
• ·Post-closing: TWO delisted from NYSE, becomes wholly owned subsidiary of CrossCountry.

29-04-2026

Anika Therapeutics reported first quarter 2026 revenue of $29.6 million, up 13% year-over-year, driven by 14% OEM Channel growth to $17.0 million and 12% Commercial Channel growth to $12.6 million, alongside gross margin expansion to 64.2% from 56.1%. Adjusted EBITDA rose to $4.3 million from $0.1 million, reflecting operational improvements, however GAAP loss from continuing operations widened to $5.1 million ($0.37 per diluted share) from approximately $4.0 million due to $4.9 million in one-time severance costs pushing operating expenses to $24.5 million. The company completed a $15 million 10b5-1 share repurchase at an average price of $10.76 per share, provided unchanged FY2026 guidance implying 1-9% total revenue growth, and announced two directors stepping down at the 2026 Annual Meeting.

• ·FY2026 guidance: Total revenue $114-$122.5M (1-9% YoY growth), Commercial Channel $53-$58M (10-20% growth), OEM Channel $61-$64.5M (flat to modestly lower), Adjusted EBITDA 5-10% of revenue
• ·Share repurchase completed April 10, 2026, at average $10.76 per share
• ·Directors Dr. Glenn Larsen and Bill Jellison to step down at 2026 Annual Meeting, not due to disagreements

29-04-2026

Chiesi Group has entered a definitive agreement to acquire KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) for $27.00 per share in cash, implying a total equity value of approximately $1.9bn, representing a 36% premium to KalVista's 30-day volume-weighted average share price as of April 28, 2026. The acquisition adds EKTERLY® (sebetralstat), the first oral on-demand therapy for hereditary angioedema (HAE), which generated $49M in US sales in 2025 following its July 2025 launch, to Chiesi's rare disease portfolio. The transaction, unanimously approved by both boards, is expected to close in Q3 2026 subject to customary conditions including regulatory approvals and tender of a majority of shares.

• ·EKTERLY® (sebetralstat) approved in US, UK, EU, Japan, Switzerland, Australia, Singapore for HAE attacks in patients 12+ years old
• ·US regulatory filing planned for 2026 to expand sebetralstat to children aged 2-11
• ·Transaction not subject to financing condition; involves tender offer followed by second-step merger
• ·Chiesi 2030 strategic revenue target of €6bn

29-04-2026

Suncrete, Inc. (Nasdaq: RMIX) completed the acquisition of Hope Concrete, LLC, a leading ready-mix company with 10 plants and 88 mixer trucks in North Texas and Southern Louisiana, expanding into two new high-growth states. The Foley family, with 80 years of experience, will continue as equity holders and operational leaders, enhancing local expertise and customer relationships. This strategic move supports Suncrete's expansion in the U.S. Sunbelt region, though integration risks are noted in forward-looking statements.

• ·Hope Concrete intended to serve as Suncrete’s Texas platform for future acquisitions.
• ·Suncrete headquartered in Tulsa, Oklahoma, previously operating in Oklahoma and Arkansas.

29-04-2026

On April 27, 2026, Tri-State Generation and Transmission Association, Inc. received notice from its Chief Administrative Officer and Chief Human Resources Officer, Elda de la Peña, that she intends to retire in December 2026 after more than 29 years of service. Tri-State plans to initiate a search for a successor. No immediate disruption to operations is indicated.

• ·Tri-State's principal executive offices: 1100 W. 116th Avenue, Westminster, Colorado 80234
• ·Telephone: (303) 452-6111
• ·Filing date: April 29, 2026

29-04-2026

Visteon Corporation executed Amendment No. 8 to its Credit Agreement on April 27, 2026, introducing new Revolving Credit Commitments of $400,000,000 to refinance existing revolving credit loans and commitments, and new Term Loans of $300,000,000 to repay outstanding Original Term Loans in full. The amendment also transfers the Administrative Agent role from Citibank, N.A. to Bank of America, N.A., with BofA Securities, Inc., JPMorgan Chase Bank, N.A., PNC Capital Markets LLC, and Wells Fargo Securities, LLC acting as joint lead arrangers. No changes in overall debt levels are indicated, maintaining the company's leverage profile.

• ·Amendment dated April 27, 2026; original Credit Agreement dated April 9, 2014
• ·All Original Revolving Credit Commitments terminated on Amendment No. 8 Effective Date
• ·Original Term Loans repaid in full with interest, fees, and other amounts using proceeds from New Term Loans

29-04-2026

On April 23, 2026, Fastenal Company held its annual meeting of shareholders in Winona, Minnesota, where shareholders approved the Fastenal Company Employee Restricted Stock Unit Plan and the Fastenal Company Non-Employee Director Stock and Restricted Stock Unit Plan. Descriptions of these plans are in the definitive Proxy Statement, with full texts filed as Exhibits 10.1 and 10.2. No other significant outcomes or changes in directors/officers were reported.

• ·Annual meeting held in Winona, Minnesota
• ·Form 8-K filed on April 29, 2026
• ·Securities: Common stock, par value $0.01 per share (FAST on Nasdaq)

29-04-2026

Green Brick Partners reported Q1 2026 net income of $60.9 million, down 18.8% YoY, with diluted EPS of $1.39 (down 16.8%) amid flat home deliveries of 908 units (-0.2% YoY) and homebuilding revenues declining 5.9% to $456.0 million. While homebuilding gross margins reached 28.9% (highest among public peers, up 320 bps adjusted), backlog revenue fell sharply 34.8% to $381.3 million with 649 units (-24.9%), though financial services revenues surged 95.2% to $9.5 million driven by mortgage growth. The company repurchased 114,000 shares for $7.2 million, maintained low leverage at 11.5% homebuilding debt to capital, and announced first sales in Houston while noting a prior periods restatement for closing cost incentives that does not impact net income or EPS.

• ·Restatement of prior periods (2023-2025 and Qs in 2024-2025) for closing cost incentives reclassified as revenue reductions; no impact on net income, EPS, gross profit, or cash flows.
• ·Average sales price of homes delivered: $493.4 (Q1 2026) vs $529.8 (Q1 2025), -6.9% YoY.
• ·Monthly sales pace: 3.4 (Q1 2026) vs 3.5 (Q1 2025).
• ·Absorption rate per community: 10.1 (Q1 2026) vs 10.6 (Q1 2025), -4.7%.
• ·Total lots owned and under contract: 48,734 at March 31, 2026 (vs 48,828 at Dec 31, 2025).

29-04-2026

At AutoNation, Inc.'s 2026 Annual Meeting on April 28, 2026, stockholders elected all nine director nominees, ratified KPMG LLP as the independent auditor for 2026, approved executive compensation on an advisory basis, and approved the 2026 Employee Equity and Incentive Plan authorizing up to 1,275,000 new shares plus 883,316 shares from the prior plan. Two stockholder proposals—an independent Board chairman and a GHG report—were overwhelmingly rejected. All management proposals passed with strong majorities exceeding 90% support in most cases.

• ·Proposal 1 (Director Elections): Votes ranged from 28,311,470 For (Jacqueline A. Travisano) to 29,278,480 For (Claire Bennett), with Against/Abstain minimal.
• ·Proposal 2 (Auditor Ratification): 31,482,534 For, 454,816 Against.
• ·Proposal 3 (Say-on-Pay): 27,776,185 For, 1,616,323 Against.
• ·Proposal 4 (2026 Plan): 29,066,751 For, 330,782 Against.
• ·Proposal 5 (Independent Chairman): 1,799,833 For, 27,561,657 Against.
• ·Proposal 6 (GHG Report): 4,387,899 For, 24,369,831 Against.
• ·2026 Plan approved by Board on January 28, 2026, subject to stockholder vote.

29-04-2026

Hawthorn Bancshares, Inc. (NASDAQ: HWBK) announced the appointment of Grant Burcham as a Class III director to its Board of Directors and that of subsidiary Hawthorn Bank, effective April 29, 2026, with his term expiring at the 2028 annual meeting of shareholders. Burcham brings over three decades of executive experience, including 34 years at Missouri Bank & Trust as Chairman and CEO, leading its growth before its 2016 sale to BOK Financial, and current roles as Managing Partner of Big Bear Ventures and Chairman of CyTek Corporation. CEO Brent Giles highlighted Burcham's entrepreneurial vision and operational discipline as key strengths for supporting the company's growth.

• ·Burcham acquired CyTek in 2021 and transformed it into a fast-growing technology company.
• ·Burcham recognized as Ernst & Young’s Entrepreneur of the Year and named to Kansas City Business Journal’s Power 100.
• ·Hawthorn Bank has served families and businesses for more than 160 years with locations in Kansas City metro, Jefferson City, Columbia, Springfield, and Clinton.

29-04-2026

On April 23, 2026, MapLight Therapeutics, Inc. directors Robert Malenka, M.D., Ph.D., and Jim Trenkle, Ph.D., notified the Board of their decision not to stand for reelection at the Annual Meeting of Stockholders on June 23, 2026. The Board nominated Martin Babler and Troy Cox as Class I director nominees to replace them. Their decisions were not due to any disagreements with the Company regarding operations, policies, or practices.

• ·Form 8-K filed on April 29, 2026, reporting event dated April 23, 2026.
• ·Company is an emerging growth company.
• ·Securities: Voting Common Stock, $0.0001 par value per share (MPLT on Nasdaq Global Select Market).

29-04-2026

Allbirds, Inc. entered into a Class A Common Stock Sales Agreement with Chardan Capital Markets LLC on April 28, 2026, allowing the company to issue and sell shares of its Class A Common Stock (par value $0.0001 per share) on an at-the-market basis through Chardan as exclusive agent, pursuant to an existing Form S-3 Registration Statement (No. 333-288434). Sales are to be initiated via Placement Notices specifying parameters such as number of shares, sales period, daily limits, and minimum price, with Chardan earning compensation per Schedule 3 (details omitted). No maximum number of shares or committed proceeds are specified, and sales are subject to conditions including suspension during material non-public information periods or earnings announcements.

• ·Agreement effective via Placement Notices; Chardan has no obligation unless notice accepted.
• ·Sales prohibited during possession of material non-public information or earnings blackout periods.
• ·Settlement occurs on the first Trading Day following sales, with Net Proceeds to Company after Chardan's commission.

29-04-2026

CalEthos, Inc. secured a $15 million loan from SFO IDF LLC, an entity controlled by a trust for family members of director Sean Fontenot, issuing a promissory note at 8% interest maturing December 31, 2028, and a 7-year warrant for 6 million shares at $0.50 per share after refinancing $1 million in prior notes to increase the principal to $16 million. Proceeds will fund a proposed joint venture for data center development, including a $6 million certificate of deposit for a gas purchase agreement. However, the letter agreement requires preferential payments to SFO IDF of up to $37.5 million from Phase 1 proceeds (company's expected 50% share of $75 million) or makeup from net income, plus $10 million per 300MW in later phases, posing future cash flow and dilution risks.

• ·Promissory note issued April 23, 2026, matures December 31, 2028.
• ·Warrant is for seven years with exercise price of $0.50 per share.
• ·Prior notes bore 10% interest and were to mature December 31, 2026.
• ·Warrant issued under Section 4(a)(2) and/or Rule 506 of Regulation D exemption.

29-04-2026

On April 23, 2026, Bruce Ledesma, Chief Legal and Compliance Officer of Nextpower Inc., informed the company of his retirement effective July 17, 2026, with the company acknowledging his significant contributions. The Board of Directors approved the appointment of Lindsey Wiedmann as the new Chief Legal and Compliance Officer effective upon Mr. Ledesma’s retirement; Ms. Wiedmann has over 15 years of legal experience in the solar industry, most recently as Chief Legal and Sustainability Officer at Maxeon Solar Technologies, Ltd.

• ·8-K filing dated April 29, 2026, reporting earliest event on April 23, 2026.
• ·Board approval of Lindsey Wiedmann's appointment on April 28, 2026.

29-04-2026

Danaher Corporation issued €3 billion in senior notes on April 29, 2026, consisting of €500 million Floating Rate Notes due 2028, €750 million 3.250% Notes due 2030, €750 million 3.625% Notes due 2034, and €1 billion 4.000% Notes due 2038, with net proceeds of approximately €2.98 billion. The proceeds are intended primarily to fund the proposed acquisition of Masimo Corporation, with possible use for general corporate purposes. The notes include special mandatory redemption at 101% if the Masimo Acquisition is not consummated by November 16, 2026, or earlier termination.

• ·Interest on Floating Rate Notes paid quarterly starting July 29, 2026; fixed rate notes paid annually starting April 29, 2027.
• ·Early redemption option prior to Par Call Dates at treasury plus 10-15 bps; at par thereafter.
• ·Notes issued under Base Indenture dated December 11, 2007, and Sixth Supplemental Indenture dated April 29, 2026.

29-04-2026

Eli Wallace, Ph.D. resigned from the Board of Directors as a Class III director, President, and CEO, effective April 20, 2026, and was succeeded by Pedro J. Beltran, Ph.D. in these roles. On April 27, 2026, the Company entered a 12-month consulting agreement with Dr. Wallace, effective retroactively from April 21, 2026, under which his sole compensation is the continued vesting of outstanding equity awards, subject to service through vesting dates. Dr. Wallace is also entitled to Tier 1 officer severance benefits pursuant to the Executive Severance Plan and a Separation Agreement dated April 27, 2026.

• ·Consulting Agreement to be filed as exhibit to Q2 2026 10-Q.
• ·Executive Severance Plan filed as Exhibit 10.23 to August 12, 2025 8-K.
• ·Stock options exercisable until earliest of 2 years post-termination or original expiration.

29-04-2026

Sprinklr, Inc. disclosed that Class II directors Yvette Kanouff and Neeraj Agrawal notified the Board on April 23, 2026, that they will not stand for re-election at the 2026 Annual Meeting and will retire upon term expiration, with no disagreements on company matters. The Board approved reducing its size from nine to seven directors effective at the Annual Meeting. Stephen M. Ward, Jr. will join the Audit Committee and Kevin Haverty the Nominating and Corporate Governance Committee at that time.

• ·Notifications received April 23, 2026; filing dated April 29, 2026.
• ·Class A Common Stock trades as CXM on NYSE.

29-04-2026

Hestia Insight Inc.'s Board unanimously approved the Strategic Divestiture and Settlement Agreement, transferring 100% interest in subsidiary Hestia Investments Inc. to Chairman and President Edward Lee to settle a $500,000 compensation liability for six years of unpaid service, thereby preserving company cash. The company retains 20% participation in the subsidiary's net earnings for two years benefiting stockholders of record as of April 30, 2026. While this avoids cash outflow, it relinquishes full ownership and control of the subsidiary.

• ·Unanimous written consent dated April 15, 2026
• ·Filing date: April 29, 2026
• ·Benefits stockholders of record as of April 30, 2026

29-04-2026

On April 28, 2026, Suketu Upadhyay informed the Vertex Pharmaceuticals board that he will not stand for re-election at the 2026 Annual Meeting due to scheduling conflicts from his new role as CFO of Incyte Corporation, with no disagreement on company matters. He will continue serving until the meeting, after which the board size will reduce to ten members. Proxy materials have been amended to remove him as a nominee, while other nominees and prior votes remain valid.

• ·Proxy materials deemed amended to remove Mr. Upadhyay as nominee; Company's slate of nominees otherwise unchanged.
• ·Previously voted proxies remain valid except with respect to Mr. Upadhyay.

29-04-2026

Shareholders of City Holding Company (NASDAQ: CHCO) elected B. Scott Raynes to its Board of Directors as a Class II director for a two-year term at the Annual Meeting on April 29, 2026, expanding the board from 11 to 12 members. Raynes, current President and CEO of Marshall Health Network, brings extensive executive experience in healthcare systems including prior roles at Southeast Georgia Health System, Baptist Hospitals, Inc., and others. City Holding Company is a $6.8 billion bank holding company and parent of City National Bank, which operates 96 branches across four states.

• ·Raynes holds a BA from West Virginia Institute of Technology, Master’s in Higher Education and Counseling from Morehead State University, and MBA with Healthcare specialization from West Virginia University.
• ·Raynes previously served as President and CEO of Southeast Georgia Health System (Jan 2022–Feb 2025), President of Baptist Hospitals, Inc. (Aug 2013–Dec 2022), and other healthcare leadership roles.

29-04-2026

On April 25, 2026, Bharat Vasan notified the Board of Directors of Starco Brands, Inc. that he resigns from the Board, effective April 27, 2026. Mr. Vasan’s departure is not the result of any disagreement with the Company on any matter relating to its operations, policies, or practices. The Board thanked Mr. Vasan for his contributions during his service.

• ·Filing date: April 29, 2026; Date of earliest event reported: April 28, 2026
• ·Resignation letter filed as Exhibit 17.1
• ·Company trades as STCB on OTC Markets Group OTCQB tier

29-04-2026

Telos Corporation announced that President, CEO, and Chairman John B. Wood is taking a medical leave of absence of uncertain duration, with no anticipated material disruption to operations; interim CEO duties are shared by Mark Griffin, Mark Bendza, and Hutch Robbins under Board oversight, while Fred Schaufeld was appointed interim Chairman. The company expects first-quarter revenue and Adjusted EBITDA above the high end of guidance provided on March 16, 2026, and plans to reaffirm its full-year outlook on the May 11, 2026 earnings call. This pre-announcement provides positive preliminary financial signals amid leadership transition uncertainty.

• ·Event date: April 28, 2026
• ·Filing date: April 29, 2026
• ·Guidance reference date: March 16, 2026
• ·Upcoming earnings call: May 11, 2026
• ·Item 2.02 information furnished, not filed, per SEC rules

29-04-2026

GD Culture Group Limited announced that its AI interactive novel app, Fato: Interactive Novel, is now publicly available for free download on the Apple App Store for iPhone and iPad users worldwide, marking a key milestone in its AI immersive reading platform initiative launched in August 2025. The app features choice-driven branching narratives, immersive chat-like interactions, and personalized story worlds in a dark mystery format. CEO Xiaojian Wang described the launch as a defining moment for the company's transition into interactive narrative entertainment.

• ·Platform concept announced and global creators invited in August 2025
• ·App download link: https://apps.apple.com/ca/app/fato-interactive-novel/id6761399590
• ·References SEC filings: 10-K on March 27, 2026; 10-Q on April 10, 2026

29-04-2026

On April 29, 2026, the Board of Directors of First American Financial Corporation and Executive Chairman Dennis J. Gilmore mutually agreed to cancel all outstanding unvested restricted stock units (RSUs) and performance-based restricted stock units (PRSUs) granted to Mr. Gilmore on June 20, 2025. The cancellation was entirely unvested and voluntary on Mr. Gilmore's part, with no exchange for other equity or cash compensation. The form of RSU and PRSU Cancellation Agreement is filed as Exhibit 10.1.

29-04-2026

Lord Abbett PCF Financing 2 LLC, borrower and affiliate of Lord Abbett Private Credit Fund, entered into Amendment No. 1 to its Loan and Security Agreement dated December 1, 2025, increasing Royal Bank of Canada's lender commitment from $300,000,000 to $400,000,000 and the Target Transaction Par Amount from $430,000,000 to $575,000,000, effective April 23, 2026. The amendment confirms no Defaults or Events of Default are occurring and that all representations and warranties remain true. Conditions precedent including legal opinions, consents, fees, and good standing certificates were satisfied.

• ·Amendment ratified original Loan Agreement except as expressly modified.
• ·Governed by New York law.
• ·Requires execution by all parties, legal opinions from Dechert LLP, fees, and good standing certificates as conditions precedent.

29-04-2026

Irenic Acquisition Corp., a SPAC sponsored by Irenic Capital Management LP, priced its $220,000,000 initial public offering of 22,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-third of a redeemable warrant exercisable at $11.50 per share. Units begin trading on Nasdaq under 'IACQU' on April 28, 2026, with separate trading of shares ('IACQ') and warrants ('IACQW') to follow, and closing expected on April 29, 2026, subject to conditions. Jefferies serves as sole book-running manager, with a 45-day over-allotment option for up to 3,300,000 additional units.

• ·SPAC focus on aerospace, defense, and broader industrial sectors for business combination.
• ·Registration statement effective April 27, 2026.

29-04-2026

Aterian, Inc. signed a definitive agreement to sell its marquee e-commerce brand portfolio—including Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct—to Trademark Global, LLC for a base cash purchase price of $18 million, subject to net working capital and other adjustments, with net proceeds expected to be distributed to stockholders in Q3 2026 potentially via a Contingent Value Right (CVR). Concurrently, the company announced a $7 million strategic investment through a private placement of convertible preferred stock with David Lazar ($3.5 million per tranche), who joined the board and will become CEO after the second tranche closes, succeeding Arturo Rodriguez. Post-sale, Aterian will operate smaller remaining legacy brands Vremi and Xtava.

• ·Proxy statement seeking stockholder approval for both transactions expected in early May 2026.
• ·Transactions expected to close in Q2 2026; net proceeds distribution (including CVR for tariffs refunds and other liquidations) in Q3 2026.
• ·Trademark Global expected to onboard majority of Aterian employees dedicated to sold brands.
• ·David Lazar and affiliates waived rights to Asset Sale proceeds and CVR.

29-04-2026

Plexus Corp reported record fiscal Q2 2026 revenue of $1.164 billion, up 19% YoY from $0.980 billion and 9% QoQ from $1.070 billion, with GAAP operating margin of 5.3% and diluted EPS of $1.82, alongside record manufacturing wins of $355 million in annualized revenue. Non-GAAP operating margin reached 6.0% and EPS $2.05, with free cash flow of $16.0 million and ROIC of 13.8%; however, top 10 customers rose to 54% of revenue, increasing concentration risk, and Q3 guidance shows GAAP operating margin declining to 4.1%-4.5% due to higher stock-based compensation. Q3 revenue guidance is $1.200-$1.250 billion (5% sequential growth at midpoint), with non-GAAP EPS of $2.02-$2.18.

• ·Cash flows from operations Q2 FY26: $28.5 million; capital expenditures: $12.5 million.
• ·Fiscal 2026 free cash flow expectation: $50-$75 million.
• ·Weighted average cost of capital FY26: 9.0%.
• ·Q3 FY26 GAAP operating margin guidance: 4.1%-4.5% (decline from Q2's 5.3%).

29-04-2026

On April 29, 2026, International Battery Metals Ltd. issued 34,315,465 Units at USD $0.08 each to EV Metals 9 LLC, an affiliate controlled by director Jacob Warnock, raising gross proceeds of USD $2.8 million as the fourth follow-on under the March 2025 LOI with EV Metals 7 LLC. Each Unit consists of one common share and one warrant exercisable at C$0.148 for four years. The Company paid a 5% structuring fee on gross proceeds to Jacob Warnock in cash.

• ·Units subject to four-month plus one-day hold period under Canadian securities laws and restricted under U.S. Securities Act.
• ·Sale relied on exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
• ·Warrants exercisable at C$0.148 per share for four years from issuance.

29-04-2026

QuickLogic Corporation (NASDAQ: QUIK) entered into a new $10 million revolving credit facility with Sunflower Bank, effective April 27, 2026, replacing its prior agreement with Heritage Bank of Commerce and providing enhanced financial flexibility for three years until maturity on April 24, 2029. The facility supports general corporate purposes, including working capital and strategic initiatives such as Strategic Radiation Hardened FPGA development for the US Government, eFPGA Hard IP licensing expansion, and the Storefront business. No declines or flat performance metrics were reported.

• ·Facility is senior secured and part of an integrated banking solution.
• ·Additional details to be included in a forthcoming Form 8-K filing.

29-04-2026

On April 23, 2026, SmartKem, Inc. funded a bridge loan to Ferrox Critical Minerals in the principal amount of $2,300,000, evidenced by a convertible promissory note maturing October 30, 2026, with 5% per annum interest and a $200,000 origination fee received by SmartKem. The note provides conversion rights into Ferrox ordinary shares at the lower of fair market value or based on an $80,000,000 fully-diluted equity value, along with protective covenants, right of first refusal on fundamental transactions, and exclusivity through maturity. No performance declines or flat metrics are reported in this filing.

• ·Note includes customary negative covenants restricting Ferrox from redeeming equity, incurring or repaying indebtedness, paying dividends, disposing of assets, amending charter, or affiliate transactions.
• ·Right of first refusal granted to SmartKem on fundamental transactions including asset sales, mergers, recapitalizations, or equity/debt issuances constituting change of control.
• ·Exclusivity granted to SmartKem on any fundamental transactions through October 30, 2026.

29-04-2026

Everspin Technologies, Inc. entered into a $40,000,000 IDIQ Subcontract (Number S26-03-01) with Amentum Services Inc. on April 24, 2026, for RDT&E services on Toggle MRAM under a prime contract with NSWC Crane. The Firm Fixed Price agreement spans a 30-month base period from April 20, 2026, to November 21, 2028, with milestone payments across two phases to develop on-shore Toggle MRAM production capability for U.S. government strategic systems. No performance declines or risks beyond standard termination clauses are noted.

• ·Subcontract structured as IDIQ with Firm Fixed Price Task Orders
• ·Company provides process know-how and IP for Toggle MRAM manufacturing
• ·Contractor may terminate for convenience only if NSWC Crane terminates Prime Contract, reimbursing vendor costs
• ·Option periods exercisable unilaterally; possible 6-month extension at final option rates
• ·Full Agreement text to be filed as exhibit to Q2 2026 10-Q

29-04-2026

XMax Inc. (XWIN) entered into Securities Purchase Agreements on April 24, 2026, with six non-U.S. investors to sell 8,550,000 shares of common stock at $3.64 per share in a Regulation S private placement, for an aggregate offering price of $31,122,000. As of April 29, 2026, the company has 63,602,326 shares of common stock issued. No financial performance metrics or period-over-period comparisons were disclosed.

• ·Private placement exempt from registration under Regulation S.
• ·Form of Securities Purchase Agreements filed as Exhibit 10.1.

29-04-2026

Xos, Inc. entered into a Confidential Separation Agreement with former General Counsel and Secretary Christen T. Romero on April 24, 2026, clarifying terms of his separation effective January 10, 2025. The agreement includes a $110,000 cash lump sum payment, full acceleration and vesting of 120,000 restricted stock units subject to a 21-month incremental lock-up, potential additional $50,000 cash if liquidity targets or transactions are achieved within three years, and reimbursement of up to $9,500 in attorney's fees.

• ·Separation Agreement attached as Exhibit 10.1
• ·Romero resigned effective January 10, 2025
• ·RSU shares released subject to incremental lock-up over 21 months
• ·Potential additional payment contingent on Company achieving liquidity targets or transactions within three-year period following April 24, 2026

29-04-2026

Professional Diversity Network, Inc. entered into a Global Amendment with Streeterville Capital, LLC on April 28, 2026, reducing the Commitment Amount in the September 5, 2025 Securities Purchase Agreement from $20,000,000 to $8,000,000, which limits potential future funding. However, the amendment introduces a mechanism allowing the Company to reduce the Minimum Balance Amount by $0.70 for every $1.00 paid toward Pre-Paid Purchases, enabling releases of at least $50,000 from the Deposit Account upon request.

• ·Global Amendment filed as Exhibit 10.1
• ·Amends Transaction Documents as previously disclosed in 8-K on September 5, 2025

29-04-2026

Cleco Corporate Holdings LLC entered into a Term Loan Agreement dated April 24, 2026, with lenders including Regions Bank as Administrative Agent, providing for term loans in an aggregate principal amount of $250,000,000 (the Term Loan Facility). The facility supports general corporate purposes with no specific performance metrics, growth comparisons, or declines reported. Applicable margins are set at 1.500% for Term SOFR Loans and Daily Simple SOFR Loans, and 0.500% for Base Rate Loans.

• ·Agreement filed as Exhibit 10.1 in 8-K on April 29, 2026
• ·Effective Date conditions outlined in Section 4.01
• ·Lenders' Commitments detailed in Schedule 2.01

29-04-2026

Lucid Group, Inc. adopted a Certificate of Designations authorizing 55,000 shares of Series C Convertible Preferred Stock, par value $0.0001 per share, with a 9% annual dividend rate payable quarterly starting June 30, 2026. The preferred stock is convertible into common stock subject to a Beneficial Ownership Limitation of 9.9% for most holders (infinity for PIF Investor) and other conditions including a Conversion Share Cap of 107.3265 common shares. No operational or financial performance metrics are provided in the filing.

• ·Dividend Payment Dates: March 31, June 30, September 30, December 31 commencing June 30, 2026.
• ·Beneficial Ownership Limitation: 9.9% of Common Stock for Other Investors; infinity for PIF Investor.
• ·Common Stock: Class A common stock, par value $0.0001 per share.

29-04-2026

Innovative Industrial Properties, Inc. (IIPR), as guarantor, supported its subsidiary IIP-IL 2 LLC in securing a $20,000,000 promissory note from Generations Bank dated April 24, 2026, filed via 8-K on April 29, 2026. The loan features a 9.00% fixed interest rate, interest-only payments until the 12-month conversion date, followed by 20-year amortization with a balloon payment at maturity on April 22, 2029, and includes a 1.50% origination fee plus tiered prepayment exit fees (3.0% year 1, 2.0% year 2, 1.0% up to 30 months). No prior period comparisons are available as this represents new financing.

• ·Loan Number: 820951505
• ·First Payment Date: May 25, 2026
• ·Conversion Date: 12 months following Effective Date (April 24, 2026)
• ·Maturity Date: April 22, 2029
• ·Prepayments prohibited before Conversion Date
• ·Late fee minimum $100, maximum $500 if payment >10 days late

29-04-2026

Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) announced the appointment of Prakash Raman, Ph.D., to its Board of Directors on April 29, 2026. Dr. Raman, current CEO of InduPro Therapeutics with prior leadership at Ribon Therapeutics, Flagship Pioneering, and Novartis, brings over two decades of biopharmaceutical expertise in business development and strategy. The appointment supports Olema's advancement of lead program palazestrant (OP-1250) through two Phase 3 trials including OPERA-01 (pivotal data expected this fall) and OP-3136, a Phase 1 KAT6 inhibitor.

• ·Dr. Raman served nearly 14 years at Novartis, most recently as Vice President, Global Head of NIBR Business Development and Licensing.
• ·Dr. Raman has served on the Board of Directors of Black Diamond Therapeutics since April 2024.
• ·Olema headquartered in San Francisco with operations in Cambridge, Massachusetts.

29-04-2026

On April 24, 2026, Jodi Devlin provided notice to TriSalus Life Sciences, Inc. of her intention to retire as Chief of Clinical Operations, effective October 1, 2026. The company previously announced on April 7, 2026, the appointment of Dr. Richard Marshall as Chief Medical Officer, effective June 29, 2026. No financial or performance impacts from these changes were disclosed.

• ·Form 8-K filed on April 29, 2026
• ·Common stock ($0.0001 par value) trades as TLSI on Nasdaq Global Market
• ·Warrants (exercisable at $11.50 per share) trade as TLSIW on Nasdaq Global Market

29-04-2026

On April 28, 2026, the Board of Directors of Farmers and Merchants Bancshares, Inc. amended and restated its 2023 Equity Compensation Plan, authorizing an additional 200,000 shares of common stock and increasing the total authorized shares under the plan to 230,000. The company intends to file a Form S-8 registration statement with the SEC to register these additional shares. Terms of the plan were previously summarized in the company's Form 8-K filed on July 19, 2023.

• ·Common stock par value $0.01 per share
• ·Company to file Registration Statement on Form S-8 for the additional shares

29-04-2026

SunPower Inc. and its subsidiaries entered into a Pledge and Security Agreement dated April 23, 2026, with U.S. Bank Trust Company, National Association as Collateral Agent, to secure 10.0% Convertible Senior Secured Notes due 2029 issued under an Indenture of the same date. The agreement grants a security interest in substantially all personal property assets as Collateral, subject to specified Excluded Assets. No principal amount for the Notes or other financial performance metrics are disclosed in the filing.

• ·Excluded Assets include fee-owned Real Property, titled vehicles, certain leases/licenses, Excluded Capital Stock, intent-to-use Trademark applications (pre-Statement of Use), governmental licenses, and assets with material adverse tax consequences.
• ·Collateral excludes more than 65% of voting stock of Foreign Subsidiaries (unless a Guarantor).
• ·Agreement filed as Exhibit 10.1 to 8-K on April 29, 2026.

29-04-2026

Anteris Technologies Global Corp., through its subsidiary Anteris Technologies Corporation, elected to discontinue additional development contributions to v2vmedtech, inc. under the April 18, 2023 Contribution and Stock Purchase Agreement after completing Stage 1 and during Stage 2, triggering a $400,000 break fee payment and termination of the related Development Agreement. v2v's initial shareholders may elect to acquire the Company's equity interest for aggregate contributions to date or reduce it to a capped minority ownership, with no decision yet communicated. The Company states this will not have a material adverse effect on its financial position or liquidity.

• ·Event occurred on April 28, 2026; filing dated April 29, 2026
• ·Discontinuation followed completion of Stage 1 during Stage 2 of the development program
• ·v2v has not yet informed the Company of its election regarding equity options

29-04-2026

XPEL, Inc. appointed Mark Thornton to its Board of Directors on April 23, 2026, with his term lasting until the Annual Meeting of Stockholders on June 10, 2026. Mr. Thornton, aged 51 with over 28 years at The Procter & Gamble Company including roles in global quality assurance and leading Pampers in Asia-Pacific, was also appointed to the Compensation and Nominating and Corporate Governance Committees. He will receive standard director indemnification and a prorated $60,000 annual cash retainer, payable in cash or shares at his option.

• ·Filing signed on April 28, 2026, reporting event of April 23, 2026
• ·XPEL common stock trades on Nasdaq under symbol XPEL, par value $0.001 per share

29-04-2026

Churchill Capital Corp XII announced the pricing of its upsized $360 million initial public offering of 36,000,000 units priced at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-tenth of one redeemable warrant exercisable at $11.50 per share. The units will list on Nasdaq under the symbol 'CXIIU' commencing April 27, 2026, with separate trading of shares ('CXII') and warrants ('CXIIW') to follow. The offering, managed by Citigroup as sole book-running manager, is expected to close on April 29, 2026, subject to customary conditions, and includes a 45-day underwriter option to purchase up to 5,400,000 additional units for over-allotments.

• ·Company founded by Michael Klein for SPAC business combinations in any industry.
• ·Underwriting agreement grants 45-day over-allotment option.
• ·Registration statement declared effective by SEC; prospectus available via Citigroup or sec.gov.

29-04-2026

Entegris, Inc. entered into Amendment No. 4 to its Credit and Guaranty Agreement dated November 6, 2018 (as previously amended), effective April 29, 2026, establishing new Revolving Commitments totaling $750 million to refinance and replace the existing Revolving Commitments. Morgan Stanley Senior Funding, Inc. acts as Administrative Agent and Collateral Agent, with Barclays Bank PLC, BofA Securities, Inc., Citibank, N.A., Goldman Sachs Bank USA, PNC Capital Markets LLC, Truist Securities, Inc., and Wells Fargo Securities, LLC appointed as joint lead arrangers and bookrunners. The amendment updates schedules, Swingline Lender commitments, Issuing Banks, and Pro Rata Shares, subject to standard conditions including solvency certification and repayment of prior obligations.

• ·Post-closing deliverables required within 90 days of Amendment No. 4 Effective Date.
• ·Existing Revolving Commitments automatically terminate on Amendment No. 4 Effective Date without further action.